Oncusp Therapeutics

OnCusp Therapeutics is a global biopharmaceutical company translating a focused portfolio of first-in-class oncology assets from promising research into proven medicines.

Health and bio

Latest funding

Series A · November 25, 2025

Amount not disclosed in a source on record.

Funding history ↓

Website: oncusptx.com.

Category: Health and bio.

Stage: Series A.

Last round: Nov 25, 2025 · 352 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredJan 15, 2021 (5 years old)

Funding rounds

November 25, 2025
Series A · amount undisclosed
Source: fundraisingfox.com
January 15, 2021
Website created

Companies like Oncusp Therapeutics

TTribune Therapeutics ABSeries A · Mar 2025
RR1 Therapeutics$80.5M Series A · Sep 2026
MModel Medicines$4.1M · Nov 2021
DDomain Therapeutics$41M Series A · May 2022
AApollo Therapeutics$226.5M Series B+ · Sep 2023
TTargED BiopharmaceuticalsSeries A · Jul 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/oncusp-therapeutics (get a free API key).